Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

In Rush to Promote High-Tech Treatments, What About Patients?



Competitive hospitals have a knack for promoting unproven high-tech therapies and surgical procedures in order to win market share. They must also foster a culture of caring for patients as people. How do marketing leaders' responsibilities align?



1 comments on "In Rush to Promote High-Tech Treatments, What About Patients?"
M. Bennet Broner, PhD (5/3/2013 at 2:32 PM)

I am surprised that health insurers do not take a more rigorous stance on paying for unvetted technologies as it would not only protect their subscribers, but their bottom line as well. That said, I would prefer a federal agency do this as is done in other countries. At the least, federal control would reduce the vagaries that would occur among private insurers.